{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:54:17Z","timestamp":1781812457592,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1016\/j.ijantimicag.2003.08.005","type":"journal-article","created":{"date-parts":[[2003,9,16]],"date-time":"2003-09-16T22:58:25Z","timestamp":1063753105000},"page":"3-13","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S1","title":["NCCLS perspectives in changing susceptibility breakpoints for antimicrobial drugs"],"prefix":"10.1016","volume":"22","author":[{"given":"John G.","family":"Gums","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB1","unstructured":"World Health Organisation. Emerging and other communicable diseases: antimicrobial resistance. Report by the Director General. WHO report A51\/9 March 10th 1998."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB2","unstructured":"FDA Task Force on antimicrobial resistance: key recommendations and report. http:\/\/www.fda.gov\/oc\/antimicrobial\/taskforce2000.html."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB3","unstructured":"World Health Organisation. Drug resistance threatens to reverse medical progress. Press release WHO\/41. June 12th 2000. http:\/\/www.who.int\/infectious-disease-report\/2000\/."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB4","unstructured":"Department of Health, UK. http:\/\/www.doh.gov.uk\/antibioticresistance\/."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB5","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1056\/NEJM199805073381909","article-title":"Multidrug resistance\u2014a sign of the times","volume":"338","author":"Levy","year":"1998","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB6","unstructured":"Alexander Project. http:\/\/www.alexander-network.com."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB7","unstructured":"Antimicrobial Resistance Management Program (ARM) Hospital medicine consensus reports, 2002. http:\/\/www.antibiotic-consult.com."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB8","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB9","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/AAC.45.10.2765-2770.2001","article-title":"Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergarten and day care centers in Hong Kong","volume":"45","author":"Chui","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB10","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/AAC.43.5.1310","article-title":"Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong","volume":"43","author":"Ho","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada","volume":"341","author":"Chen","year":"1999","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB12","unstructured":"Tang P, Green K, McGeer A, et al. Antibiotic resistance trends in Canadian strains of Streptococcus pneumoniae\u2014results from 9 consecutive years of surveillance, Proceedings of the 42nd interscience conference on antimicrobial agents and chemotherapy. San Diego, USA, 2002. Abstract C2-1631."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB13","unstructured":"Tang P, Green K, McGeer A, et al. Emerging resistance in respiratory tract isolates of Streptococcus pneumoniae in Canada, Proceedings of the 42nd interscience conference on antimicrobial agents and chemotherapy. San Francisco, USA, 2002. Abstract L-992."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB14","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJM199911113412013","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae","volume":"341","author":"Linares","year":"1999","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0924-8579(02)00125-5","article-title":"Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999\u20132000","volume":"20","author":"Critchley","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/jac\/41.3.420","article-title":"Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland","volume":"41","author":"Goldsmith","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB17","unstructured":"Ferraro MJ, Brown S, Harding I. Prevalence of fluoroquinolone resistance amongst Streptococcus pneumoniae isolated in the United States during the winter of 2000\u20132001, Proceedings of the 42nd interscience conference on antimicrobial agents and chemotherapy. San Diego, USA, 2002. Abstract C2-650."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/AAC.41.2.471","article-title":"Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones","volume":"41","author":"Pan","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jac\/45.5.583","article-title":"Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones","volume":"45","author":"Pestova","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB20","unstructured":"Lim S, Bast DJ, De Azevado JJCS, McGeer A, Low DE. Failure of current susceptibility testing methodologies to detect first step Streptococcus pneumoniae mutants, Proceedings of the 42nd interscience conference on antimicrobial agents and chemotherapy. San Francisco, USA, 2002. Abstract D-30."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0924-8579(02)00120-6","article-title":"Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin","volume":"20","author":"Browne","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB22","unstructured":"Tang P, Green K, McGeer A, et al. Fluoroquinolone resistance in Streptococcus pneumoniae in Canada\u2014are we surveying just the tip of the iceberg, Proceedings of the 42nd interscience conference on antimicrobial agents and chemotherapy. San Diego, USA, 2002. Abstract C2-1632."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB23","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"346","author":"Davidson","year":"2002","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB24","unstructured":"National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; 12th informational supplement, M100-S12. Wayne, PA, USA, 2002."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain","volume":"333","author":"Pallares","year":"1995","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00006454-200104000-00005","article-title":"Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriaxone in children treated with \u03b2-lactam antibiotics","volume":"20","author":"Kaplan","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB27","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1001\/archinte.161.21.2538","article-title":"A fresh look at the susceptibility of Streptococcus pneumoniae to \u03b2-lactam antibiotics","volume":"161","author":"Musher","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB28","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/AAC.22.4.622","article-title":"Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis","volume":"22","author":"Del Rio","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00003495-198427060-00001","article-title":"Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use","volume":"27","author":"Richards","year":"1984","journal-title":"Drugs"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2003.08.005_BIB30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/26.suppl_A.1","article-title":"Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. Time courses of free and total concentrations of cefotaxime and ceftriaxone in serum and pleural exudate","volume":"26","author":"Scaglione","year":"1990","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB31","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1128\/JCM.40.2.669-674.2002","article-title":"In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations","volume":"40","author":"Sahm","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB32","unstructured":"Sahm DF, Mayfield DC, Jones ME, Master RN, Karlowsky JA, Thornsberry C. In vitro activity of commonly prescribed antimicrobials against pneumococcal isolates from patients over 65 years of age, Proceedings of the annual meeting of the Infectious Diseases Society of America, 2001. San Francisco, USA. Abstract 512."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB33","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/jac\/dkf231","article-title":"Comparability of antimicrobial susceptibility test results from 22 European countries and Israel: an external quality assurance exercise of the European Antimicrobial Resistance Surveillance System (EARSS) in collaboration with the United Kingdom National External Quality Assurance Scheme (UK NEQAS)","volume":"50","author":"Bronzwaer","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.005_BIB34","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1183\/09031936.02.00400402","article-title":"Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections","volume":"36","author":"Klugman","year":"2002","journal-title":"Eur. Respir. J. Suppl."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903002772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903002772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T16:05:06Z","timestamp":1585152306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857903002772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":34,"alternative-id":["S0924857903002772"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2003.08.005","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}